← FDA Drug Approvals (Drugs@FDA)
JEMPERLI
BLA · Biologics License Application · Sponsor: GLAXOSMITHKLINE · Approved 2021-04-22
Drug application
- FDA Application #
BLA761174- Application type
- Biologics License Application
- Brand name
- JEMPERLI
- Generic name
- DOSTARLIMAB
- Active ingredients
- DOSTARLIMAB-GXLY
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- GLAXOSMITHKLINE
- Manufacturer
- GlaxoSmithKline LLC
- First approval
- 2021-04-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown